1-9 of 9
Keywords: Cancer Patients
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2023) 101 (5): 328–342.
Published Online: 09 May 2023
... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2023 Tobacco treatment Cancer patients Oncologist Smoking cessation...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (1984) 41 (Suppl. 1): 78–81.
Published Online: 17 June 2009
...A. Barduagni; M. Barduagni; Di Lauro; M. Nardi; Gallo Curcio; R. Tonachella; G.B. Ciottoli; Delle Chiaie Lonidamine was studied in advanced cancer patients. The drug was given orally by single or repeated administrations. Single doses ranged from 150 to 450 mg. Repeated administrations were...
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (1984) 41 (Suppl. 1): 48–52.
Published Online: 17 June 2009
...J.-G. Besner; R. Leclaire; P.R. Band; M. Deschamps; A.J. De Sanctis; B. Catanese The pharmacokinetics of lonidamine has been studied in cancer patients after single and chronic oral administrations. After single administration the plasma kinetics are highly variable, while the dose eliminated...
Journal Articles
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (1984) 41 (2): 77–82.
Published Online: 11 June 2009
...T.A. Koppi; J.M. Khan; W.J. Halliday Leucocytes from 4 cancer patients showed cellular reactivity in the leucocyte adherence inhibition (LAI) assay in the presence of the synthetic encephalitogenic peptide of human myelin basic protein. All patients exhibited reactivity at a peptide concentration...